このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Video-based First-contact Physiotherapy in Primary Care (VIPP)

2026年8月24日 更新者:Vastra Gotaland Region

Video-based First-contact Consultation With a Physiotherapist in Primary Care for Patients With Musculoskeletal Symptoms

This study aims to evaluate the effects and implications of using video-based first-contact consultation in primary care physiotherapy, compared with traditional in-person consultation for musculoskeletal symptoms. The participants with musculoskeletal symptoms will receive either a video-based first contact physiotherapy consultation or an in-person first-contact physiotherapy consultation and will be followed for up to two years. The project addresses clinical effectiveness, healthcare utilisation, cost-effectiveness, and carbon footprint, according to the following specific aims.

Objectives

  • To evaluate whether a video-based first-contact consultation with a physiotherapist is not clinically inferior to an in-person first-contact consultation, using the Patient-Specific Functional Scale (PSFS) as the primary outcome measure and multiple secondary outcomes assessed over time.
  • To analyse healthcare utilisation in primary and specialist care at 12 and 24 months following a video-based first-contact consultation, compared with an in-person first contact consultation.
  • To evaluate whether a video-based first-contact consultation with a physiotherapist is cost-effective from a healthcare perspective and in terms of environmental impact compared with an in-person first contact consultation.

調査の概要

詳細な説明

Background The digitalisation of health care has accelerated in recent years, driven by the World Health Organisation's Global Strategy on Digital Health. Musculoskeletal conditions include diseases and disorders affecting the joints, bones, muscles and related connective tissues. These conditions can affect multiple body areas or systems. Furthermore, the conditions are often characterised by pain and limitations in mobility and activities of daily living. Globally, musculoskeletal conditions are estimated to affect 1.7 billion people. Musculoskeletal conditions represent approximately two-thirds of all adults requiring rehabilitation. Physiotherapy plays a central role in the management and rehabilitation of musculoskeletal conditions. When provided as first-line primary care, physiotherapy has proven both efficient and cost-effective . Furthermore, video-based physiotherapy has been associated with improved attendance and adherence, factors that are critical for treatment effectiveness.

Video-based assessment in physiotherapy has been shown to be partially valid and reliable, but the methods remain poorly standardised, and the use of approaches and technical tools varies considerably. Overall, the evidence is limited, and existing descriptions are insufficient to support implementation in clinical practice. The transition to video-based care is described as a paradigm shift, and the profession expresses uncertainty regarding its effectiveness.

Despite the promising potential of digital health encounters, several challenges remain. A substantial proportion of patients initially assessed via video subsequently require in-person visits. Moreover, the therapeutic relationship may be affected by the video-based format. Taken together, these factors highlight an urgent need for robust, long-term evaluations of video-based first-contact physiotherapy.

Methods Study design A pragmatic randomised controlled trial (RCT) with a non-inferiority design will be conducted. The study will evaluate whether a video-based first-contact consultation with a physiotherapy yields outcomes that are not clinically inferior to those of a standard in-person first-contact physiotherapy consultation in primary care. The study will be reported in accordance with the CONSORT 2010 Statement for non-inferiority trials.

A non-inferiority analysis will be conducted, as the study aims to determine whether video-based first-contact physiotherapy consultation is not clinically inferior to an in-person first-contact physiotherapy. The analysis will use a predefined margin (∆) based on both statistical considerations and clinical judgement. The minimal clinically important difference and change for the PSFS was considered to define the non-inferiority margin. Previous literature reports that the minimal clinically important change for the PSFS ranges from approximately 1.3 and 2.3 points, depending on the diagnostic area. To ensure that any potential difference between groups is not clinically relevant, the non-inferiority margin has been set at ∆ = 1.5 points, which is also consistent with previous research in digital physiotherapy. The standard deviation (SD) will be set to 2, based on previous studies .

Sample size calculations based on the primary outcome variable PSFS, with ∆ = 1.5, indicate that 78 participants per group are required to achieve 80% statistical power with a one-sided alpha of 2.5%. Assuming a 25 % dropout rate, 104 participants will be included in each group, for a total of 208 participants.

Participant Selection and Recruitment Participants aged 18 years or older with musculoskeletal symptoms will be recruited. The study will be conducted at approximately six regional primary care rehabilitation units in Region Västra Götaland, Sweden, representing both geographic and demographic variation.

Potential participants will be identified through advertisement via social media, through posters and telephone. Potential participants will be screened to ensure that they meet the inclusion and exclusion criteria. They will receive written participant information digitally, will have the opportunity to ask questions, and will be offered verbal information. Informed consent will be obtained digitally.

Participants will be stratified by age, randomised, and scheduled for the type of consultation (video or in-person) corresponding to their allocated group with participating physiotherapist. All collected data will be handled in accordance with the principal investigator's data management procedures and applicable legislation.

Procedures The video-based first-contact consultation and the in-person first-contact consultation will be conducted within routine care. Participating physiotherapists will undergo approximately five hours of training in a structured model for conducting video-based physiotherapeutic assessments.

Participants will complete digital questionnaires before the first consultation, immediately after the first consultation, and at 6 weeks, 3 months, 6 months, and 12 months. The estimated time required to complete the digital questionnaires is approximately 10-20 minutes. Medical records and registry data will be collected in 6, 12 and 24 months.

Statistical Analysis The analyses will be conducted using IBM SPSS Statistics for Windows, (IBM Corp., Armonk, NY, USA). Descriptive statistics will be presented as means, standard deviations, and medians for continuous variables, and as frequencies for categorical variables.

Comparisons of improvement levels will be conducted using regression models, controlling for potential confounders (e.g., age, gender, trust). Comparisons of proportions showing improvement will be performed using a two-proportion Z-test. Exploratory analyses will be conducted to identify predictors of outcomes within the video consultation group.

For the health economic analysis, QALYs will be calculated from EQ-5D-5L data, and cost data will be obtained from healthcare registers and patient records. Incremental cost-effectiveness ratios (ICERs) will be calculated, with uncertainty analyses performed using bootstrapping and cost-effectiveness acceptability curves.

Estimates of carbon dioxide emissions will be performed from a life-cycle perspective, based on patient travel and estimates from the Swedish Transport Administration, healthcare utilisation based on estimates from the National Health Service in England, and the use of digital technology.

Comparisons between groups and over time will be conducted using appropriate parametric or non-parametric tests and regression models, depending on the characteristics of the data. Matched analyses will be applied where relevant.

研究の種類

介入

入学 (推定)

208

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Age 18 years or older.
  • Musculoskeletal complaints.
  • Sufficient linguistic and cognitive ability to read, understand, and complete a web-based application form and provide informed consent in Swedish.
  • Willing to attend the clinic in person.

Exclusion Criteria:

  • Ongoing treatment for the current condition with planned follow-up by a physiotherapist.
  • Lack of access to technology capable of supporting video consultations (e.g., smartphone, computer, or tablet).

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:ヘルスサービス研究
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Video-based first-contact physiotherapy
Participants receive a video-based first-contact physiotherapy consultation. Following the first-contact consultation, participants will receive standard individualised physiotherapy treatment which falls outside the scope of the study.
Participants receive a video-based first-contact physiotherapy consultation. Following the assessment, individualised standard physiotherapy treatment is provided as needed. During the video-based assessment, participants will be in a setting of their choice and will meet a physiotherapist via video. The physiotherapists will be trained in a structured model for conducting video-based physiotherapeutic assessments. The rehabilitation clinic's standard platform for real-time audio and video healthcare visits will be used. The estimated time will be approximately 30-45 minutes.
アクティブコンパレータ:Traditional in-person first-contact physiotherapy
Participants receive an in-person physiotherapy consultation at a primary care rehabilitation clinic. Following the first-contact consultation, participants will receive standard individualised physiotherapy treatment which falls outside the scope of the study.
Participants receive an in-person physiotherapy consultation at a primary care rehabilitation clinic. Following the assessment, individualised standard physiotherapy treatment is provided as needed. The traditional in-person consultation will be conducted at a rehabilitation clinic within the public healthcare system in Region Västra Götaland. The estimated time will be approximately 30-45 minutes.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Patient-Specific Functional Scale (PSFS) at 6 weeks
時間枠:6 weeks
Evaluates treatment outcomes by having the patient identify three activities limited by their condition and rate them on a scale from 0 to 10, where 0 = "unable to perform activity" and 10 = "able to perform activity at the same level as before injury or problem" (Stratford et al., 1995).
6 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Patient-Specific Functional Scale (PSFS) at baseline
時間枠:Baseline
Evaluates treatment outcomes by having the patient identify three activities limited by their condition and rate them on a scale from 0 to 10, where 0 = "unable to perform activity" and 10 = "able to perform activity at the same level as before injury or problem" (Stratford et al., 1995).
Baseline
Patient-Specific Functional Scale (PSFS) at 3 months
時間枠:3 months
Evaluates treatment outcomes by having the patient identify three activities limited by their condition and rate them on a scale from 0 to 10, where 0 = "unable to perform activity" and 10 = "able to perform activity at the same level as before injury or problem" (Stratford et al., 1995).
3 months
Patient-Specific Functional Scale (PSFS) at 6 months
時間枠:6 months
Evaluates treatment outcomes by having the patient identify three activities limited by their condition and rate them on a scale from 0 to 10, where 0 = "unable to perform activity" and 10 = "able to perform activity at the same level as before injury or problem" (Stratford et al., 1995).
6 months
Patient-Specific Functional Scale (PSFS) at 12 months
時間枠:12 months
Evaluates treatment outcomes by having the patient identify three activities limited by their condition and rate them on a scale from 0 to 10, where 0 = "unable to perform activity" and 10 = "able to perform activity at the same level as before injury or problem" (Stratford et al., 1995).
12 months
Pain intensity using Numeric Rating Scale (NRS) at baseline
時間枠:Baseline
Current pain is rated on a numeric scale from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain (Hjermstad et al., 2011).
Baseline
Pain intensity using Numeric Rating Scale (NRS) at 6 weeks
時間枠:6 weeks
Current pain is rated on a numeric scale from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain (Hjermstad et al., 2011).
6 weeks
Pain intensity using Numeric Rating Scale (NRS) at 3 months
時間枠:3 months
Current pain is rated on a numeric scale from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain (Hjermstad et al., 2011).
3 months
Pain intensity using Numeric Rating Scale (NRS) at 6 months
時間枠:6 months
Current pain is rated on a numeric scale from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain (Hjermstad et al., 2011).
6 months
Pain intensity using Numeric Rating Scale (NRS) at 12 months
時間枠:12 months
Current pain is rated on a numeric scale from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain (Hjermstad et al., 2011).
12 months
Patient's Global Impression of Change (PGIC) at 6 weeks
時間枠:6 weeks
The Patient's Global Impression of Change (PGIC) assesses the patient's perception of change. Patients rate their change since the start of treatment on a 7-point scale, where 1 indicates "very much improved" and 7 indicates "very much worse" (Hurst & Bolton, 2004).
6 weeks
Patient's Global Impression of Change (PGIC) at 3 months
時間枠:3 months
The Patient's Global Impression of Change (PGIC) assesses the patient's perception of change. Patients rate their change since the start of treatment on a 7-point scale, where 1 indicates "very much improved" and 7 indicates "very much worse" (Hurst & Bolton, 2004).
3 months
Perceived quality of care, Quality from the Patient's Perspective (QPP) at day 1
時間枠:Day 1
Perceived quality of care will be assessed using the Quality from the Patient's Perspective (QPP) questionnaire, which measure patients 'experiences of healthcare quality from the patient's perspective across several domains/factors medical-technical competence, physical-technical conditions identity-oriented approach, socio-cultural atmosphere. Patients first rate their experience based on "this is how it was for me", which reflects the perceived reality. They then rate "this is how important it was for me", corresponding to subjective importance. Responses are provided using Likert scale. (Wilde Larsson & Larsson).
Day 1
Perceived quality of care, Quality from the Patient's Perspective (QPP) at 6 weeks
時間枠:6 weeks
Perceived quality of care will be assessed using the Quality from the Patient's Perspective (QPP) questionnaire, which measure patients 'experiences of healthcare quality from the patient's perspective across several domains/factors medical-technical competence, physical-technical conditions identity-oriented approach, socio-cultural atmosphere. Patients first rate their experience based on "this is how it was for me", which reflects the perceived reality. They then rate "this is how important it was for me", corresponding to subjective importance. Responses are provided using Likert scale. (Wilde Larsson & Larsson).
6 weeks
Quality of life measured with EuroQol Dimensions - 5 Levels (EQ-5D-5L) at Baseline
時間枠:Baseline
The EQ-5D-5L is a health-related quality of life instrument consisting of two parts. The first part is a self-assessment of quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension rated on five levels of severity. The second part is a rating using a visual analogue scale (VAS) from 0 to 100, where 0 represents the worst imaginable health and 100 represents the best imaginable health (EuroQol Research Foundation, n.d.).
Baseline
Quality of life measured with EuroQol Dimensions - 5 Levels (EQ-5D-5L) at 6 weeks
時間枠:6 weeks
The EQ-5D-5L is a health-related quality of life instrument consisting of two parts. The first part is a self-assessment of quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension rated on five levels of severity. The second part is a rating using a visual analogue scale (VAS) from 0 to 100, where 0 represents the worst imaginable health and 100 represents the best imaginable health (EuroQol Research Foundation, n.d.).
6 weeks
Quality of life measured with EuroQol Dimensions - 5 Levels (EQ-5D-5L) at 3 months
時間枠:3 months
The EQ-5D-5L is a health-related quality of life instrument consisting of two parts. The first part is a self-assessment of quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension rated on five levels of severity. The second part is a rating using a visual analogue scale (VAS) from 0 to 100, where 0 represents the worst imaginable health and 100 represents the best imaginable health (EuroQol Research Foundation, n.d.).
3 months
Quality of life measured with EuroQol Dimensions - 5 Levels (EQ-5D-5L) at 6 months
時間枠:6 months
The EQ-5D-5L is a health-related quality of life instrument consisting of two parts. The first part is a self-assessment of quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension rated on five levels of severity. The second part is a rating using a visual analogue scale (VAS) from 0 to 100, where 0 represents the worst imaginable health and 100 represents the best imaginable health (EuroQol Research Foundation, n.d.).
6 months
Quality of life measured with EuroQol Dimensions - 5 Levels (EQ-5D-5L) at 12 months
時間枠:12 months
The EQ-5D-5L is a health-related quality of life instrument consisting of two parts. The first part is a self-assessment of quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension rated on five levels of severity. The second part is a rating using a visual analogue scale (VAS) from 0 to 100, where 0 represents the worst imaginable health and 100 represents the best imaginable health (EuroQol Research Foundation, n.d.).
12 months
Work Ability Index (WAI) at Baseline
時間枠:Baseline
Self-rated work ability will be measured with WAI. Questionnaire consisting of a total 10 questions of seven items, sometimes only one question is used. The index addresses demand of work, the worker's health status and resources (Illmarinen, 2007; Svenska WAI-nätverket, n.d.).
Baseline
Work Ability Index (WAI) at 6 weeks
時間枠:6 weeks
Self-rated work ability will be measured with WAI. Questionnaire consisting of a total 10 questions of seven items, sometimes only one question is used. The index addresses demand of work, the worker's health status and resources (Illmarinen, 2007; Svenska WAI-nätverket, n.d.).
6 weeks
Work Ability Index (WAI) at 3 months
時間枠:3 months
Self-rated work ability will be measured with WAI. Questionnaire consisting of a total 10 questions of seven items, sometimes only one question is used. The index addresses demand of work, the worker's health status and resources (Illmarinen, 2007; Svenska WAI-nätverket, n.d.).
3 months
Work Ability Index (WAI) at 6 months
時間枠:6 months
Self-rated work ability will be measured with WAI. Questionnaire consisting of a total 10 questions of seven items, sometimes only one question is used. The index addresses demand of work, the worker's health status and resources (Illmarinen, 2007; Svenska WAI-nätverket, n.d.).
6 months
Work Ability Index (WAI) at 12 months
時間枠:12 months
Self-rated work ability will be measured with WAI. Questionnaire consisting of a total 10 questions of seven items, sometimes only one question is used. The index addresses demand of work, the worker's health status and resources (Illmarinen, 2007; Svenska WAI-nätverket, n.d.).
12 months

その他の成果指標

結果測定
メジャーの説明
時間枠
Demographic data
時間枠:Baseline
Background information such as age, sex, level of education and occupation.
Baseline
General self-efficacy
時間枠:Baseline
One question regarding participants general self-efficacy before the first-contact consultation (Di et al., 2023).
Baseline
Trust in digital care using Patient Trust Assessment Tool (PATAT)
時間枠:Baseline
To measure trust in telemedicine the Patient trust Assessment Tool (PATAT) will be used. PATAT is a self-reported instrument developed to measure patients' trust in healthcare services in the context of telemedicine or digital care. The instrument consists of 25 items, where the patient rate statements on a five-point Likert scale ranging from disagree (1) to agree (5). The questionnaire consisting of one question in each of five domains: trust in the healthcare organization, healthcare personnel, treatment, technology, and telemedicine (Van Velsen et al., 2017).
Baseline
Total travel time to the clinic
時間枠:Day 1
Total travel time to the clinic for the participant's first-contact consultation, or the estimated travel time to the clinic where an in-person visit would otherwise have taken place in the case of a video consultation. For participants receiving a video consultation, the travel time represents the time they would have spent travelling to an in-person consultation.
Day 1
Mode of transport to the clinic
時間枠:Day 1
Mode of transport used to travel to the clinic for the participant's first-contact consultation. For participants receiving a video consultation, the mode of transport they would have used to attend an in-person consultation will be recorded.
Day 1
Technology used for video consultation
時間枠:Day 1
Type of technology used by the participant to conduct the video consultation.
Day 1
Consultation duration
時間枠:Day 1
Duration of the physiotherapy first-contact consultation, measured in minutes.
Day 1
Administrative time
時間枠:Day 1
Duration of administrative activities associated with the physiotherapy consultation, measured in minutes.
Day 1
Number of adverse events
時間枠:Day 1
Number of adverse events occurring during the first-contact consultation.
Day 1
Physiotherapist-rated adherence to the structured approach
時間枠:Day 1
Physiotherapists rate the extent to which they followed the structured approach taught during the study training using a 0-10 numerical rating scale, where 0 = strongly disagree and 10 = strongly agree.
Day 1
Physiotherapist-rated sufficiency of information to proceed with treatment
時間枠:Day 1
Physiotherapists rate whether they obtained sufficient information from the first-contact consultation to proceed with treatment using a 0-10 numerical rating scale, where 0 = strongly disagree and 10 = strongly agree.
Day 1
Participant's areas of complaint
時間枠:Day 1
The participant's area of complaint as recorded by the physiotherapist at the first-contact consultation.
Day 1
Visit information -obtained from the physiotherapists
時間枠:Day 1
  • Consultation and administrative duration.
  • Adverse events.
  • Adherence to the structured video-based approach.
  • Whether sufficient information was obtained to proceed with treatment
  • Participant's area of complaint.
Day 1
Diagnostic code at the first-contact consultation
時間枠:Approximately 6 months after study start
ICD-10 diagnosis code from the participant´s first-contact consultation with a physiotherapist at the rehabilitation clinic where the participant attended the first study visit. These data will be collected after all participants have been enrolled.
Approximately 6 months after study start
Procedure codes (KVÅ) at the first-contact consultation
時間枠:Approximately 6 months after study start
Procedure codes (KVÅ) from the participant´s first-contact consultation with a physiotherapist at the rehabilitation clinic where the participant attended the first study visit. These data will be collected after all participants have been enrolled.
Approximately 6 months after study start
Number of previous rehabilitation visits
時間枠:Approximately 6 months after study start
All visits and visit modalities at regional primary care rehabilitation clinics during the two years before the participant´s first visit in the study. These data will be collected after all participants have been enrolled.
Approximately 6 months after study start
Number of physiotherapy visits during the current episode of care, at 12 months
時間枠:Approximately 12 months after study start
All physiotherapy visits related to the current episode of care, including visit modality (digital or in-person), from study start up to 12 months.
Approximately 12 months after study start
Number of physiotherapy visits during the current episode of care, at 24 months
時間枠:Approximately 24 months after study start
All physiotherapy visits related to the current episode of care, including visit modality (digital or in-person), from study start up to 24 months.
Approximately 24 months after study start
Number of other Healthcare contacts, 12 months
時間枠:Approximately 12 after study start
All other healthcare contacts, including visit modality, within primary care, specialized outpatient care and inpatient care during the study period. The data will cover the period from study start until 12 months after the participant´s first-contact consultation.
Approximately 12 after study start
Number of other Healthcare contacts, 24 months
時間枠:Approximately 24 months after study start
All other healthcare contacts, including visit modality, within primary care, specialized outpatient care and inpatient care during the study period. The data will cover the period from study start until 24 months after the participant´s first-contact consultation.
Approximately 24 months after study start
Total healthcare costs during 12 months
時間枠:Approximately 12 months after study start
Information on healthcare costs associated with healthcare contacts recorded during the study period, to the extent that such information is available. Total healthcare costs will be calculated based on the recorded healthcare contacts and applicable unit costs and will be used for health economic and cost-effectiveness analyses.
Approximately 12 months after study start
Total healthcare costs during 24 months
時間枠:Approximately 24 months after study start
Information on healthcare costs associated with healthcare contacts recorded during the study period, to the extent that such information is available. Total healthcare costs will be calculated based on the recorded healthcare contacts and applicable unit costs and will be used for health economic and cost-effectiveness analyses.
Approximately 24 months after study start
Number of physiotherapy visits related to the condition
時間枠:12 months
Physiotherapy records may be reviewed during study period and up to one year after the first consultation in order to capture whether the visits were related to the current episode of care and to describe the content of assessments and treatments. The purpose is to ensure an accurate link between healthcare utilisation and the condition for which the participant is included in the study.
12 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Elvira Lange, PhD、Vastra Gotaland Region

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年10月1日

一次修了 (推定)

2028年12月31日

研究の完了 (推定)

2030年12月31日

試験登録日

最初に提出

2026年8月10日

QC基準を満たした最初の提出物

2026年8月24日

最初の投稿 (実際)

2026年8月26日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月26日

QC基準を満たした最後の更新が送信されました

2026年8月24日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • VIPP
  • 2025 (米国 NIH グラント/契約:Faculty of Social Sciences Scientific Grant at the University of Gdańsk)
  • 2025-07915 (その他の助成金/資金番号:Swedish Research Council)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

Individual participant data (IPD) will not be publicly shared due to restrictions under the EU General data Protection Regulation (GDPR). However anonymised data may be made available upon reasonable request, provided the request complies with GDPR and Swedish data protection regulations.

IPD 共有時間枠

After ethical approval. Anticipated date: Oktober 1st 2026. End: Available as long as R&D Project Database in Region Västra Götaland is available.

IPD 共有アクセス基準

Individual participant data (IPD) will be provided if the request complies with GDPR and Swedish data protection regulations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する